Source: Annual Congress 2001 - Factors contributing to upper and lower airway responses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Zervas, M. Gaga, G. Papatheodorou, V. Kehagia, M. Stoka, A. Preza, L. Andri, N. Papageorgiou, I. Iordanoglou (Athens, Greece). Magnesium levels in erythrocytes and plasma in patients with exacerbated COPD. Eur Respir J 2001; 16: Suppl. 31, 2891

Member's Comments

No comment yet.

Related content which might interest you: Increased blood lead and cadmium levels in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 413s Year: 2001 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Calcium and magnesium blood levels of COPD patients with respiratory muscle dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 163s Year: 2006 Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Myeloperoxidase increased in plasma in patients with stable COPD Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Bronchospastic eicosanoids in blood and urine of patients with stable and exacerbated COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Can plasma arginase levels differantiate asthma and COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017